What Antidepressants Actually Do (and What They Don’t)

A lot of people start antidepressants without fully understanding what they’re taking or what to expect from it. The prescription gets written, the directions say take one in the morning, and somewhere in between there’s a quiet uncertainty that doesn’t always get addressed: what is this actually doing inside me?

That question deserves a real answer. Not a reassurance, not a simplified version, but an honest explanation of what antidepressants are doing at a biological level, why they work for some people and not others, what they can’t do that people sometimes expect, and what the experience of taking them actually tends to look like.

Understanding this doesn’t make the decision to start or stay on medication easier or harder. It just makes it more informed.

Depression is not a simple chemical imbalance

Before getting into what antidepressants do, it’s worth addressing something that has been repeated so often it’s become the default explanation: that depression is caused by a chemical imbalance, specifically low serotonin, and that antidepressants fix it by correcting that imbalance.
This explanation is not accurate, and it’s worth saying so clearly.

The chemical imbalance theory of depression was a working hypothesis that gained popular traction in the 1990s, largely through pharmaceutical marketing, and it has since been substantially revised within psychiatry and neuroscience. Depression is far more complex than a single neurotransmitter deficit. It involves disruption across multiple brain systems including serotonin, dopamine, and norepinephrine pathways, as well as changes in neuroplasticity, inflammatory processes, the HPA axis and stress response system, and the structure and connectivity of specific brain regions involved in mood, motivation, and threat processing.

This matters because if depression were simply “low serotonin,” antidepressants that increase serotonin availability should work for everyone, quickly and reliably. They don’t. Understanding why helps clarify what these medications are actually doing.

What antidepressants are actually doing

The most commonly prescribed antidepressants are SSRIs, selective serotonin reuptake inhibitors, and SNRIs, serotonin-norepinephrine reuptake inhibitors. These medications work by blocking the reuptake of neurotransmitters in the synaptic cleft, the space between neurons where chemical signaling happens.

When a neuron releases serotonin, it normally gets reabsorbed fairly quickly by the releasing neuron. SSRIs block this reabsorption process, which means serotonin stays in the synaptic cleft longer and has more opportunity to bind to receptors on the receiving neuron. SNRIs do the same for both serotonin and norepinephrine.

What’s important to understand is that this effect is immediate. Within hours of taking an SSRI, there’s more serotonin activity in the synapse. But most people don’t feel better within hours. They feel better, if they do, after two to six weeks. Sometimes longer.

This gap between the pharmacological effect and the clinical effect is one of the most significant and least-explained aspects of antidepressant treatment. The reason for it is that the actual therapeutic change isn’t happening at the level of the synapse. It’s happening downstream.

The current understanding is that sustained changes in neurotransmitter activity over weeks trigger a cascade of neuroplastic changes, particularly in a region called the hippocampus, which is consistently found to show reduced volume and reduced neurogenesis in people with depression. Antidepressants appear to promote the growth of new neurons in this region, a process called neurogenesis, and to strengthen synaptic connections in circuits involved in mood regulation. These structural changes take time to develop, and they’re thought to be much closer to the actual mechanism of therapeutic benefit than the immediate synaptic effect.

There are other classes of antidepressants worth knowing about. Bupropion works primarily on dopamine and norepinephrine and is often used when energy, motivation, or concentration are prominent symptoms, or when sexual side effects from SSRIs are a concern. Mirtazapine works through a different mechanism involving histamine and multiple serotonin receptor subtypes and tends to be sedating, making it useful when insomnia and appetite loss are significant. TCAs, tricyclic antidepressants, and MAOIs, monoamine oxidase inhibitors, are older classes that are still used in specific situations, particularly treatment-resistant cases, though they come with more complex side effect and dietary consideration profiles.

Why they work for some people and not others

This is the question that frustrates patients most, and understandably so.
The honest answer is that psychiatry does not yet have reliable biological markers that predict individual antidepressant response. Prescribing still involves a degree of informed trial and error, guided by a person’s symptom profile, history, family medication history, any relevant medical conditions, and clinical judgment.
What is known is that different people metabolize medications differently due to genetic variation in liver enzymes, particularly the cytochrome P450 system. Some people are rapid metabolizers who clear a drug so quickly that standard doses produce little effect. Others are poor metabolizers who experience what would normally be side effects at doses that should be therapeutic. Pharmacogenomic testing, which analyzes these genetic variants, is available and can meaningfully inform prescribing decisions, though it doesn’t eliminate the need for clinical judgment.

There are also non-biological factors that affect response. Chronic stress, inadequate sleep, social isolation, ongoing trauma, and alcohol use can all blunt or prevent antidepressant response even when the medication would otherwise be effective. Depression is not a purely biological event, and treating it with only a biological tool has limits. This is a significant part of why research consistently shows that the combination of medication and therapy produces better outcomes than either alone for most people with moderate to severe depression.

The response rate for the first antidepressant tried is approximately 50 percent. For people who don’t respond to the first, trying a different medication, adjusting the dose, adding an augmentation agent, or switching classes often leads to response eventually. The STAR*D study, one of the largest real-world antidepressant trials conducted, found that approximately two thirds of people with major depressive disorder achieved remission with one to four treatment steps, though each step requires time and often involves its own period of adjustment.

What antidepressants don’t do

This is where expectations and reality sometimes diverge, and where having a clear picture matters.
Antidepressants are not mood elevators in the way people sometimes imagine. They don’t produce happiness. They don’t generate positive emotion on their own. What most people who respond to them describe is a reduction in the weight of depression, the heaviness, the inability to feel motivated, the emotional numbness or reactivity, the cognitive fog. The floor lifts. Things that felt impossible start feeling possible. But the medication doesn’t do the living for you, and it doesn’t create meaning or connection or address the things in a person’s life that may be contributing to depression.

Antidepressants don’t work immediately. The two-to-six week window for noticing meaningful change is real, and stopping in the first week because nothing has happened is one of the most common reasons treatment fails. Some people feel slightly worse in the first one to two weeks before they feel better, particularly with activating medications like SSRIs, due to initial effects on anxiety before the mood effects develop.

Antidepressants don’t eliminate all symptoms for everyone. Partial response, where some symptoms improve but others remain, is common, and recognizing it as partial response rather than full response is important so that treatment can be adjusted rather than left incomplete.

They also don’t solve problems that exist outside the brain. A medication cannot change a relationship, a work environment, a pattern of thinking that developed over years, or a trauma that hasn’t been processed. What it can do is create enough neurobiological stability that a person has the capacity to address those things, whether through therapy, life changes, or both. The medication creates a floor. The work of building something above that floor still requires effort and support.

Side effects, honestly

Every medication has side effects, and antidepressants are no exception. What’s worth knowing is that side effects tend to be most pronounced in the first one to two weeks of treatment and often diminish significantly as the body adjusts. The side effects that persist beyond that initial adjustment period are more clinically relevant and worth discussing with a prescriber.

Common early side effects with SSRIs and SNRIs include nausea, headache, sleep changes, increased anxiety or restlessness, and gastrointestinal disruption. Most of these resolve within two weeks. Starting at a lower dose and titrating up gradually can reduce their intensity.
The side effects that are more likely to persist and more commonly lead people to discontinue medication are sexual dysfunction, which affects a meaningful proportion of people on SSRIs and SNRIs and often goes undisclosed because people don’t think to mention it or feel embarrassed doing so, weight changes, which vary by medication and individual, and emotional blunting, a flatness or muting of emotional range that some people find troubling even when the depression itself has improved.

These are worth raising directly with a prescriber. They are manageable in many cases, either through dose adjustment, switching to a different medication with a different side effect profile, or adding a complementary treatment. What doesn’t help is tolerating them in silence and either staying on a medication that’s causing problems or stopping it abruptly without medical guidance.

Taking medication alongside therapy

The research on this is consistent enough to be worth stating plainly. For most people with moderate to severe depression, the combination of antidepressant medication and psychotherapy produces better outcomes than either treatment alone.

The reason makes clinical sense. Medication can reduce the neurobiological burden of depression, making it more possible to engage in therapy, to retain what’s learned in sessions, to have the cognitive and emotional capacity to do the work. Therapy can address the patterns, beliefs, relationships, and circumstances that medication cannot reach. The two work on different levels and complement each other.

This is part of the reasoning behind Vantage’s integrated approach. Psychiatric care and therapy at the same clinic means the people involved in a patient’s care are in communication, and treatment decisions are being made with a full picture rather than in isolation.

When the goal is coming off medication

There’s a narrative circulating online, particularly on social media, that psychiatrists don’t know how to help patients stop antidepressants, or that deprescribing, the careful, planned reduction or discontinuation of medication, isn’t something that happens in standard psychiatric care. That narrative is worth correcting directly.

Deprescribing is a recognized and practiced part of psychiatric medication management. It requires the same clinical skill and attention as starting a medication, and in some ways more, because the process needs to account for the individual’s history, the specific medication and dose, how long they’ve been on it, and what’s happening in their life at the time.

At Vantage, the team is highly trained in deprescribing, including hyperbolic tapering, an approach based on the pharmacological principle that reductions of equal percentage, rather than equal milligrams, produce more stable transitions because of how receptors respond to proportional changes in drug concentration. For some medications and some people, this means tapering over months rather than weeks, at a pace that keeps the nervous system stable throughout.

What that process looks like is built collaboratively. There is no universal deprescribing schedule. The plan is tailored to the person, adjusted based on how they’re responding, and revisited at each step. The goal is to get to the other side with as little disruption as possible, and to do it in a way that doesn’t undo what the medication helped build.

If you’re thinking about coming off medication, that’s a conversation worth having with a prescriber who has the expertise to do it properly. The process doesn’t have to be difficult. It just has to be done thoughtfully.

If you have questions about your own medication

A lot of people carry questions about their antidepressants that never quite get asked. Whether it’s working, whether the side effects are normal, whether there’s something better suited to their situation, whether they’re on the right dose. These are not small questions, and they deserve a proper conversation with a prescriber who has time to engage with them.

Vantage Mental Health offers psychiatric medication management at clinics in Stillwater, Edina, and St. Anthony, and via telehealth across Minnesota. If you’re currently on medication and something isn’t right, or if you’re trying to figure out whether medication might be part of what helps you, a real conversation is the right place to start.

Book an appointment at Vantage Mental Health